Søgning
Søgning på udtrykket 'hepatitis c' giver 39 resultater
Dokumenter [2] Sider [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [15]
Dokumenter [2]
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Sider [1]
…is: Akut viral hepatitis: Carsten Shade Larsen (tovholder) og Nina Weis.
Professor Henrik Nielsen kommenterer: I disse år sker et paradigmeskift i behandlingen af kronisk hepatitis C virus infektionen. Mange direkte virkende lægemidler er i afprøvning og med lovende resultater. Snart er interferon-baseret terapi ikke absolut nødvendig, mens oral terapi af kort varighed synes indenfor rækkevidde. Samtidigt er bivirkninger ved de nye lægemidler hidtil beskrevet som milde og sjældne.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
17.01.2025
by Ajit Patil, Pallavi Vidhate, Sandip Patil, Amrita Rao, Swarali Kurle, Samiran Panda . Viral hepatitis is a major public health challenge. Hepatitis C Virus (HCV) infection causes the progressive liver damage.
Clinical Infectious Diseases
15.01.2025
Clinical Infectious Diseases
11.01.2025
Abstract . Background . Chronic hepatitis C virus (HCV) infection affects >1% of the U.S. population, higher among U.S. Veterans. Direct-acting antiviral (DAA) medications are effective for viral cure, termed sustained virologic response (SVR), but repeat viremia after SVR is recognized. Prior work has been limited by use of electronic medical record data. We aim to better understand repeat viremia in the DAA era through detailed chart review.Methods .
PLoS One Infectious Diseases
1.01.2025
by Sayamon Hongjaisee, Woottichai Khamduang, Nang Kham-Kjing, Nicole Ngo-Giang-Huong, Arunrat Tangmunkongvorakul . During the COVID-19 pandemic, sex workers (SW) were one of the vulnerable groups affected by lockdown measures. COVID-19 had also disrupted HIV/Sexually transmitted infection (STI) testing and treatment services for sex workers due to numerous restrictions in specialist medical care.
New England Journal of Medicine
29.12.2024
New England Journal of Medicine, Ahead of Print.
BMJ Open
25.12.2024
. Objectives. This study aimed to explore the spatial and temporal distribution of hepatitis C and its influencing factors in Chongqing, providing a scientific basis for the relevant departments to formulate targeted preventive measures for the high prevalence of hepatitis C in the region and population. . Design.
Journal of Medical Virology
19.12.2024
Journal of Medical Virology, Volume 96, Issue 12, December 2024.
Clinical Infectious Diseases
19.12.2024
Abstract . Background . Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir/velpatasvir (SOF/VEL) in pregnant versus nonpregnant people.Methods . Pregnant people with chronic HCV infection were enrolled between 23-25 weeks’ gestation and were provided SOF/VEL daily for 12 weeks. PK visits were performed at 3, 6 and 9 weeks.
Lancet Microbe
10.12.2024
WHO has prequalified the first self-test for hepatitis C virus (HCV), specifically designed for lay users.
Science Advances
7.12.2024
Science Advances, Volume 10, Issue 49, December 2024.
Infection
4.12.2024
. Abstract. . Purpose. HCV treatment has been revolutionized by introduction of direct-acting antiviral therapy (DAA). Short treatment duration of eight to twelve weeks combined with significantly improved tolerability opened the opportunity to reach out to difficult-to-treat populations.
Clinical Infectious Diseases
28.11.2024
Abstract . Background . Hepatitis C virus (HCV) elimination requires treating people who use drugs (PWUD), yet fewer than 10% of PWUD in the United States access HCV treatment and access is especially limited in rural communities.Methods . We randomized PWUD with HCV viremia and past 90-day injection drug or non-prescribed opioid use in seven rural Oregon counties to peer-assisted telemedicine HCV treatment (TeleHCV) versus peer-assisted referral to local providers (enhanced usual care; EUC).
Journal of Medical Virology
15.11.2024
Journal of Medical Virology, Volume 96, Issue 11, November 2024.
BMJ Open
9.11.2024
. Introduction. Hepatitis C virus (HCV) infection is a silent epidemic that needs a comprehensive and contextualised approach to manage. Access to readily available, affordable and acceptable HCV point-of-care (POC) in vitro diagnostics (IVDs) is equally required to meet the global HCV goals. However, most guidelines for evaluating these IVDs such as the WHO prequalification process and country-specific standards disproportionately focus on diagnostic performance.
Journal of Acquired Immune Deficiency Syndromes
27.10.2024
Background: . Little is known about the effect of HCV treatment on sexual risk behaviour among men who have sex with men (MSM) with HIV by treatment type (IFN-based vs DAA-based). Setting: . MSM with HIV and recently acquired HCV infection enrolled in the observational MOSAIC cohort. Methods: . Using data from 2009-2018, we evaluated risk behaviour through a validated HCV risk score (where ≥2 indicated high risk) and its individual risk behaviours.
Journal of Medical Virology
22.10.2024
Journal of Medical Virology, Volume 96, Issue 10, October 2024.
Journal of Infectious Diseases
17.10.2024
Abstract . Background . Both HIV and hepatitis C virus (HCV) infection increase the risk of hepatic steatosis (HS), which in turn contributes to the severity and progression of liver disease. Direct acting antivirals (DAAs) can cure HCV but whether they reduce HS is unclear.Methods . HS was assessed using the controlled attenuation parameter (CAP) and the hepatic steatosis index (HSI) in participants coinfected with HIV-HCV from the Canadian Coinfection Cohort.
BMJ Open
16.10.2024
. Introduction. Patient-reported measures are an invaluable resource for health systems to improve the quality of healthcare services. Patients with hepatitis C virus (HCV) are an under-represented group within the stream of literature on collecting and using the experiences and outcomes reported by patients to improve healthcare performance.
BMC Infectious Diseases
28.09.2024
. Abstract. . Background. Hepatitis C virus (HCV) antibody self-testing (HCVST) may help expand screening access and support HCV elimination efforts. Despite potential benefits, HCVST is not currently implemented in Pakistan. This study aimed to assess the usability and acceptability of HCVST in a high HCV prevalence informal settlement in Karachi, Pakistan. . . .
PLoS One Infectious Diseases
24.09.2024
…C. Wilson, Willi McFarland . Background Transgender women (hereafter “trans women”) face social marginalization, stigma, and discrimination and experience a high burden of HIV. More recently, trans women have been identified as having a high risk for hepatitis C (HCV) infection. The interaction between these two diseases and the risks for HIV/HCV co-infection among trans women are understudied.
Aktuelle smitsomme sygdomme [15]
Aktuelle smitsomme sygdomme [15]
ProMED
20.01.2025
. . . HEPATITIS C - PAKISTAN: INCREASED NUMBERS. *****************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Sun 12 Jan 2025 . Source: The Dawn [edited] . www.dawn.com/news/1884593/pakistan-tops-world-in-hepatitis-c-cases-pms-aide . . . Pakistan tops world in hepatitis C cases: PM's aide . --------------------------------------------- .
Eurosurveillance latest updates
15.11.2024
. Background. Hepatitis C virus (HCV) infection is targeted for elimination as a public health threat by 2030. The World Health Organization goal for treatment uptake is ≥ 80% among cases diagnosed with an active HCV infection (RNA- or core antigen-positive), maintained for 2 years. . . Aim. To calculate treatment uptake, time from diagnosis to treatment start and complete treatment dispensation among notified cases of HCV infection in Norway. . . Method.
Medscape Infectious Diseases
7.11.2024
The rate of HCV reinfection was high in the immediate posttreatment period among individuals who injected drugs but decreased significantly over time. . Medscape Medical News
Medscape Infectious Diseases
28.09.2024
The study highlighted that 57.7% of neonates in the case group had a diagnosis of neonatal abstinence syndrome compared to 10.0% in the control group. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
2.08.2024
This report describes progress toward eliminating hepatitis B and C in the country of Georgia.
Eurosurveillance latest updates
26.07.2024
. Introduction. Obtaining epidemiological data on chronic hepatitis C virus (HCV) infection is essential to monitor progress towards the hepatitis C elimination targets. . . Aim. We aimed to estimate the prevalence of chronic HCV and the seroprevalence of HCV in the adult general population in Estonia. . . Methods.
Eurosurveillance latest updates
26.07.2024
. Introduction. A national study from 2006 to 2008 showed a high antibody prevalence of 3.2% against hepatitis C virus (HCV) in Romania, but more recent epidemiological data on hepatitis C prevalence are lacking. . . Aim. We aimed to estimate the current prevalence of HCV antibodies (anti-HCV) and chronic HCV infection in the general adult population in Romania, as a crucial element in monitoring progress towards eliminating hepatitis C. . . Methods.
Eurosurveillance latest updates
26.07.2024
.
Eurosurveillance latest updates
20.07.2024
. Background. People who use drugs (PWUD) are a key target population to reduce the burden of hepatitis C virus (HCV) infection. . . Aim. To assess risk factors and temporal trends of active HCV infection in PWUD in Madrid, Spain. . . Methods. We conducted a retrospective study between 2017 and 2023, including 2,264 PWUD visiting a mobile screening unit. Data about epidemiology, substance use and sexual risk behaviour were obtained through a 92-item questionnaire.
Eurosurveillance latest updates
20.07.2024
. Background. Active follow-up of chronic hepatitis C notifications to promote linkage to care is a promising strategy to support elimination. . . Aim. This pilot study in Victoria, Australia, explored if the Department of Health could follow-up on hepatitis C cases through their diagnosing clinicians, to assess and support linkage to care and complete data missing from the notification. . . Methods.
Morbidity and Mortality Weekly Report (MMWR)
31.05.2024
This report describes hepatitis C viral clearance proportions among people with hepatitis C by state.
Medscape Infectious Diseases
2.01.2025
Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing. . Medscape Medical News
Eurosurveillance latest updates
8.11.2024
…th 95% confidence intervals (CI) for having basic knowledge and explanatory variables: sociodemographic characteristics, history of hepatitis C and/or HIV diagnosis, sexual orientation disclosure at last sexually transmitted infections (STI) test and outness. . . Results. Of 113,884 participants across 43 WHO European Region countries, 68% demonstrated basic knowledge, ranging from 50% in Israel to 80% in the Netherlands. Basic knowledge was significantly associated with older age (≥ 40 years vs
Eurosurveillance latest updates
8.11.2024
…large pan-European MSM Internet Survey (EMIS-2017), we analysed data on self-reported hepatitis A and B vaccination status by age, education, financial coping, settlement size, outness (disclosure of sexual behaviour), migration history and diagnosis with hepatitis C or HIV, using multivariable logistic regression. Additionally, we collected information on national hepatitis A and B vaccination recommendations. . . Results. We present data of 113,884 MSM, median age 36 years (IQR: 27–47).
Eurosurveillance latest updates
26.10.2024
. Background. Hepatitis E, a viral hepatitis caused mainly by the ingestion of raw or undercooked food, is not a notifiable disease in Spain. . . Aim. To analyse the temporal trends, epidemiological characteristics and factors associated with severe disease from hepatitis E hospitalisations in Spain from 1997 to 2019. . . Methods. Hospitalisation records were obtained from the Spanish National Hospital Discharge Database.